The hereditary amyloidosis market is witnessing significant momentum driven by advancements in therapeutic options and increasing awareness of this rare genetic disorder. This specialized sector showcases robust growth potential, supported by ongoing innovations and expanding patient populations globally. Comprehensive market analysis highlights pivotal opportunities aligned with emerging...